Beta 3 Agonist Treatment in Heart Failure-2

NCT03926754 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction NYHA Class III-IV

Interventions

DRUG: Mirabegron

Sponsor

Henning Bundgaard

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]